On February 21st, the inaugural Entrepreneur Appreciation Conference of Lingang Park took place on the second floor of the G60 Science and Technology Innovation Building. During this grand event, ConFlow MedTech received the "Excellent Enterprise Award" for the year 2022 from Lingang Joint Park.
This award highly affirms ConFlow MedTech's the comprehensive strength, scientific and technological innovation prowess, and future growth potential in the field of cardiovascular medicine. ConFlow MedTech remains committed to its core principle of pursuing excellence and fostering collaboration. Our primary focus continues to be on advancing R&D in innovative cardiovascular devices, enhancing our scientific and innovative capabilities, and strengthening our product development prowess. We are dedicated to driving the clinical adoption of cutting-edge medical technologies in the cardiovascular arena, with the ultimate goal of improving the lives of more patients suffering from cardiovascular diseases.